Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04040296 · ClinicalTrials.gov registry record · NA
Personalized Recommendations for Acute Kidney Injury (AKI) Care
A NA study of Acute Kidney Injury, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 4,003
- Enrollment target
- 1
- Study location
NCT04040296 is a NA study of Acute Kidney Injury that has completed, run by Yale University. The registered enrollment target is 4,003 participants, above the 2,277-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (76% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04040296, a NA study of Acute Kidney Injury, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,003 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized clinical trial of a "Kidney Action Team", which will provide timely, personalized recommendations for the diagnosis and initial treatment of hospitalized patients with Acute Kidney Injury (AKI).
Conditions Studied
Interventions
- OTHER Kidney Action Team Recommendations
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,003 participants |
| Start Date | 2021-10-29 |
| Est. Completion | 2024-02-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04040296
The ClinicalTrials.gov registry entry for NCT04040296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4,003 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,277-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (76% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Kidney Injury appearing as the primary indexed condition, and to 1 intervention - of which Kidney Action Team Recommendations is the first listed.
NCT04040296 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04040296 about?
NCT04040296 is a clinical study titled "Personalized Recommendations for Acute Kidney Injury (AKI) Care". This is a randomized clinical trial of a "Kidney Action Team", which will provide timely, personalized recommendations for the diagnosis and initial treatment of hospitalized patients with Acute Kidney Injury (AKI).
What is the current status of trial NCT04040296?
This trial is currently completed. It is a NA study. The enrollment target is 4,003 participants. The study started on 2021-10-29. Estimated completion is 2024-02-22.
What conditions does trial NCT04040296 study?
This clinical trial studies the following conditions: Acute Kidney Injury.
What interventions are being tested in trial NCT04040296?
The interventions under investigation include: Kidney Action Team Recommendations (OTHER).
Who is sponsoring clinical trial NCT04040296?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04040296 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
-
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
RECRUITING · NA
-
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
RECRUITING · NA
-
CTSN Embolic Protection Trial
RECRUITING · NA
-
A Study of Facilitators and Barriers to Improve Acute Kidney Injury in Children Through Mobile Health Intervention
RECRUITING · NA
-
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.